Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
3
Atlas Venture, Lightstone Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Manas AI is the AI-native biopharmaceutical company. We combine pioneering AI technology with the first principles of chemistry, physics…
Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key…
Tribune TherapeuticsVenture round $40M · 17 mo ago • Founded 2020
Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a…
Abinitio bio is the AI-native operating platform for drug development and manufacturing.
At Prellis Biologics, we harness AI and immune diversity to advance next-gen medicines. Discover our EXIS™ platform and bioprinting…
Immunai13 roles
We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics.

Overview

Discover how Day One Biopharmaceuticals is disrupting the status quo of traditional drug development to bring new medicines to children and adults with cancer.

News

Blog 8 months ago
Lydia's story
.subhero-short__block { background: url(https://www.dayonebio.com/wp-content/uploads/2024/09/Masthead-Basic-blue.png) no-repeat 0 0; background-size: cover; } @media (max-width: 567px) { .subhero-short__block { background: url(https://www.dayonebio.com/wp
Read more
Report
Blog 9 months ago
A First-in-Class Opportunity with Emi-Le, A Novel ADC
.subhero-short__block { background: url(https://www.dayonebio.com/wp-content/uploads/2024/09/Masthead-Basic.png) no-repeat 0 0; background-size: cover; } @media (max-width: 567px) { .subhero-short__block { background: url(https://www.dayonebio.com/wp-cont
Read more
Report
Blog 1 year ago
Kids With Brain Tumors Deserve Better
.subhero-short__block { background: url(https://www.dayonebio.com/wp-content/uploads/2024/09/Masthead-Basic.png) no-repeat 0 0; background-size: cover; } @media (max-width: 567px) { .subhero-short__block { background: url(https://www.dayonebio.com/wp-cont
Read more
Report
Blog 1 year ago
Meeting the Moment: Transforming Oncology Care Through Innovation, Urgency, and Empathy
.subhero-short__block { background: url(https://www.dayonebio.com/wp-content/uploads/2024/09/Masthead-Basic.png) no-repeat 0 0; background-size: cover; } @media (max-width: 567px) { .subhero-short__block { background: url(https://www.dayonebio.com/wp-cont
Read more
Report
Blog 1 year ago
Jeremy Bender on Biotech2050
.subhero-short__block { background: url(https://www.dayonebio.com/wp-content/uploads/2024/09/Masthead-Basic.png) no-repeat 0 0; background-size: cover; } @media (max-width: 567px) { .subhero-short__block { background: url(https://www.dayonebio.com/wp-cont
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.